Increase/Decrease in Cash: The total change in cash for the company over the given period.
Edesa Biotech, Inc. (EDSA) had Increase/Decrease in Cash of $-1.09M for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-1.68M |
|
-- |
|
-- |
|
$1.86M |
|
$-1.86M |
|
$0.18M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.86M |
|
$-1.81M |
|
3.13M |
|
3.13M |
|
$-0.54 |
|
$-0.54 |
|
Balance Sheet Financials | |
$5.42M |
|
$0.01M |
|
$2.42M |
|
$7.83M |
|
$1.99M |
|
-- |
|
-- |
|
$1.99M |
|
$5.84M |
|
$3.69M |
|
$5.84M |
|
3.16M |
|
Cash Flow Statement Financials | |
$-1.41M |
|
-- |
|
$0.31M |
|
$5.36M |
|
$4.27M |
|
Increase/Decrease in Cash |
$-1.09M |
$0.18M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.72% |
|
-45.48% |
|
-21.43% |
|
-28.72% |
|
$1.85 |
|
$-0.45 |
|
$-0.45 |